文献速递主动脉疾病

优化荷兰外科动脉瘤审计中的风险校正

Toward Optimizing Risk Adjustment in the Dutch Surgical Aneurysm Audit.
PubMed 文献 · Ann Vasc Surg · 2019-05-08

本研究基于荷兰外科动脉瘤审计(DSAA)2013–2016年前瞻性登记的12,401例患者,旨在确定与死亡率相关的最佳术前变量集以建立病例组合模型。最佳变量集包含性别、年龄、肺部合并症、手术时机、肌酐、动脉瘤大小、血红蛋白、格拉斯哥昏迷评分、心电图和收缩压,C统计量为0.871,优于VBHOM、DAS和GAS模型。

要点

  • 最佳病例组合模型包含临床与实验室变量,C统计量0.871。
  • 总体术后死亡率为6.5%,择期手术后1.8%,急性症状后6.6%,破裂后29.6%。
  • 该变量集可从电子病历中方便获取,有助于高效风险校正。

核心结论

  • DSAA的最佳病例组合校正变量集包含临床和实验室参数,可高效构建病例组合模型。

研究设计与样本

  • 前瞻性纳入2013–2016年DSAA登记的12,401例患者,其中择期手术9,537例(76.9%),急性症状913例(7.4%),破裂1,951例(15.7%)。
  • 对缺失变量进行多重插补后,经单变量logistic回归筛选预测因子,再行手动后退多变量logistic回归,并与GAS、VBHOM、DAS三个标准死亡风险预测模型比较。

主要发现

  • 总体术后死亡率为6.5%;择期手术后1.8%,急性症状后6.6%,破裂后29.6%。
  • 与死亡率相关的最佳独立变量集为性别、年龄、肺部合并症、手术时机、肌酐、动脉瘤大小、血红蛋白、格拉斯哥昏迷评分、心电图和收缩压(C统计量0.871)。
  • 外部验证总体VBHOM、DAS和GAS的C统计量分别为0.836、0.782和0.761,H-L检验P值分别为0.028、0.00和0.128。

关键数值与推荐

  • 判别力良好定义为C统计量>0.8,校准良好定义为Hosmer-Lemeshow检验P>0.05。
  • 最佳模型C统计量0.871;VBHOM的C统计量0.836,H-L P=0.028;DAS的C统计量0.782,H-L P=0.00;GAS的C统计量0.761,H-L P=0.128。

临床怎么用

  • 可采用包含性别、年龄、肺部合并症、手术时机、肌酐、动脉瘤大小、血红蛋白、GCS、心电图和收缩压的变量集进行病例组合校正。
  • 这些变量可从电子病历中方便获取,便于高效风险校正。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To compare hospital outcomes of aortic aneurysm surgery, casemix correction for preoperative variables is essential. Most of these variables can be deduced from mortality risk prediction models. Our aim was to identify the optimal set of preoperative variables associated with mortality to establish a relevant and efficient casemix model. METHODS: All patients prospectively registered between 2013 and 2016 in the Dutch Surgical Aneurysm Audit (DSAA) were included for the analysis. After multiple imputation for missing variables, predictors for mortality following univariable logistic regression were analyzed in a manual backward multivariable logistic regression model and compared with three standard mortality risk prediction models: Glasgow Aneurysm Score (GAS, mainly clinical parameters), Vascular Biochemical and Haematological Outcome Model (VBHOM, mainly laboratory parameters), and Dutch Aneurysm Score (DAS, both clinical and laboratory parameters). Discrimination and calibration were tested and considered good with a C-statistic > 0.8 and Hosmer-Lemeshow (H-L) P > 0.05. RESULTS: There were 12,401 patients: 9,537 (76.9%) elective patients (EAAA), 913 (7.4%) acute symptomatic patients (SAAA), and 1,951 (15.7%) patients with acute rupture (RAAA). Overall postoperative mortality was 6.5%; 1.8% after EAAA surgery, 6.6% after SAAA, and 29.6% after RAAA surgery. The optimal set of independent variables associated with mortality was a mix of clinical and laboratory parameters: gender, age, pulmonary comorbidity, operative setting, creatinine, aneurysm size, hemoglobin, Glasgow coma scale, electrocardiography, and systolic blood pressure (C-statistic 0.871). External validation overall of VBHOM, DAS, and GAS revealed C-statistics of 0.836, 0.782, and 0.761, with an H-L of 0.028, 0.00, and 0.128, respectively. CONCLUSIONS: The optimal set of variables for casemix correction in the DSAA comprises both clinical and laboratory parameters, which can be collected easily from electronic patient files and will lead to an efficient casemix model.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lijftogt N, Vahl A, van der Willik EM, et al. Toward Optimizing Risk Adjustment in the Dutch Surgical Aneurysm Audit. Ann Vasc Surg. 2019. PMID: 31075453. doi:10.1016/j.avsg.2019.02.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。